Author

R. Astles

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 1 Approach:deep learning· 1 Research Focus:drug response / drug discovery· 1 Organism:human· 1 Assay:whole-genome sequencing· 1

Frequent Co-Authors

A. Bigdeli· 1 shared A. Lehman· 1 shared A. Perl· 1 shared B. Manning· 1 shared G. W. Schwartz· 1 shared J. Morrissette· 1 shared M. Carroll· 1 shared P. Velu· 1 shared

Activity by Year

2018-2018 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

A. Bigdeli

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Classes of ITD predict outcomes in patients with AML treated with FLT3 inhibitors

G. W. Schwartz, B. Manning, Y. Zhou, P. Velu, A. Bigdeli, R. Astles, A. Lehman, J. Morrissette, A. Perl, M. Carroll, R. Faryabi

The paper classifies FLT3-ITD mutations into typical and atypical based on nucleotide composition and shows typical ITD carriers have better outcomes with FLT3 inhibitors.

bioRxiv · May 14, 2018Cancer Biology